Career Development in Clinical Hematology Research

临床血液学研究的职业发展

• 批准号: 7193649
• 负责人: Janis L Abkowitz
• 金额: $ 39.92万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-28 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7193649
• 关键词: career; clinical research; health science research potential; hematology; mentoring /mentor

DESCRIPTION (provided by applicant): This grant application requests funds to support a career development program in benign hematology clinical research at the University of Washington and affiliated Seattle institutions. It will function as a bridge for fellows between their clinical fellowship (and initial research time, generally supported by a T32 award) and the successful acquisition of a K08, K23, or equivalent award. Our goal is to be flexible and to individualize a career development plan for each scholar that consists of core clinical experiences and didactic and practical research experiences. Multidisciplinary research is encouraged and faculty in the Departments of Medicine (i.e., Divisions of Hematology, Medical Oncology, General Internal Medicine, Medical Genetics, Allergy and Infectious Diseases), Pediatrics, Laboratory Medicine, Genome Sciences, Biostatistics, and Anesthesiology are included as mentors. We anticipate funding five scholars (each for two years over the course of the five year grant cycle). We have integrated an extensive mentorship program into our K12 plan as we believe that this is a critical element to assure a scholar's successful transition from fellow to faculty. We anticipate that the scholars will progress to tenure track academic appointments at our institution or elsewhere. The broad goal of our application is to promote benign hematology clinical research, as this is an underserved field.

描述（由申请人提供）： 该赠款申请要求资金支持华盛顿大学良性血液学临床研究的职业发展计划和西雅图附属机构。它将作为他们临床奖学金（和最初的研究时间，通常由T32奖）和成功获得K08，K23或同等奖项的研究员之间的桥梁。我们的目标是灵活，并为每个学者个性化职业发展计划，包括核心临床经验以及教学和实践研究经验。鼓励和教师在医学部门（即血液学，医学肿瘤学，通用内科，医学遗传学，过敏和传染病），儿科，实验室医学，基因组科学，生物统计学和麻醉学。我们预计将资助五名学者（在整个五年赠款周期的过程中每人两年）。我们已经将广泛的指导计划纳入了我们的K12计划，因为我们认为这是确保学者从同伴到教师的成功过渡的关键要素。我们预计学者将在我们机构或其他地方的任期前进。我们应用的广泛目标是促进良性血液学临床研究，因为这是一个服务不足的领域。